Stratasys Releases Fourth Quarter and Full Year 2022 Financial Results
Stratasys Ltd. (SSYS) reported its fourth quarter 2022 revenue at $159.3 million, down 4.6% year-on-year, but adjusted for divestitures, it rose 1.7%. The company posted a GAAP net loss of $2.4 million or $0.04 per diluted share, while non-GAAP net income was $4.6 million, or $0.07 per share. For the full year, revenue increased 7.3% to $651.5 million, with a GAAP net loss of $29 million, or $0.44 per share. Cash and equivalents totaled $327.8 million with no debt. The company has provided a 2023 revenue guidance of $620 million to $670 million amid challenging market conditions.
- Full year revenue grew 7.3% to $651.5 million.
- Non-GAAP operating income improved to $13.5 million in 2022 from an operating loss in 2021.
- Adjusted EBITDA for 2022 was $36.1 million, up from $22.6 million in 2021.
- Cash and equivalents stand at $327.8 million, ensuring financial stability.
- Fourth quarter revenue decreased 4.6% year-over-year.
- GAAP net loss of $29 million for the full year, greater than prior year's loss.
- Planned inventory build caused cash used in operations of $75.4 million.
-
Fourth quarter revenue of
,$159.3 million 4.6% lower versus fourth quarter 2021 but up1.7% at constant currency and adjusted for divestitures -
Fourth quarter GAAP net loss of
, or$2.4 million per diluted share, and non-GAAP net income of$0.04 , or$4.6 million per diluted share$0.07 -
Full year revenue of
,$651.5 million 7.3% higher versus 2021 and up11.4% at constant currency and adjusted for divestitures -
Full year GAAP net loss of
, or$29.0 million per diluted share, and non-GAAP net income of$0.44 , or$10.3 million per diluted share$0.15 -
cash and equivalents and no debt at year end 2022$327.8 million
Dr.
Summary - Fourth Quarter 2022 Financial Results Compared to Fourth Quarter 2021:
-
Revenue of
compared to$159.3 million .$167.0 million -
GAAP gross margin of
43.1% , compared to43.7% . -
Non-GAAP gross margin of
48.4% , compared to48.7% . -
GAAP operating income of
, compared to an operating loss of$1.6 million .$16.2 million -
Non-GAAP operating income of
, compared to non-GAAP operating income of$5.1 million .$1.7 million -
GAAP net loss of
, or$2.4 million per diluted share, compared to a net loss of$0.04 , or$4.8 million per diluted share.$0.07 -
Non-GAAP net income of
, or$4.6 million per diluted share, compared to non-GAAP net income of$0.07 , or$0.5 million per diluted share.$0.01 -
Adjusted EBITDA of
, compared to$10.7 million .$7.9 million -
Planned inventory build resulted in cash used in operations of
, compared to cash generated of$18.1 million year over year.$4.4 million
Summary - 2022 Financial Results Compared to 2021:
-
Revenue of
compared to$651.5 million .$607.2 million -
GAAP gross margin of
42.4% , compared to42.8% . -
Non-GAAP gross margin of
48.0% , compared to47.8% . -
GAAP operating loss of
, compared to a$57.2 million operating loss.$79.2 million -
Non-GAAP operating income of
, compared to a$13.5 million non-GAAP operating loss.$1.7 million -
Adjusted EBITDA of
, compared to$36.1 million .$22.6 million -
GAAP net loss of
, or ($29.0 million ) per diluted share, compared to a loss of$0.44 , or ($62.0 million ) per diluted share.$0.98 -
Non-GAAP net income of
, or$10.3 million per diluted share, compared to non-GAAP net loss of$0.15 , or$4.3 million per diluted share.$(0.07) -
Planned inventory build resulted in cash used in operations of
, compared to cash provided by operations of$75.4 million .$35.8 million
Non-GAAP Adjustments: | |||||
Quarter Ended
|
Year Ended
|
||||
Revenue Growth Rates (%) as reported |
(4.6 |
%) |
|
7.3 |
% |
Adjusted Revenue Growth Rates (%) excluding divestitures |
(0.3 |
%) |
|
9.0 |
% |
Adjusted Revenue Growth Rates (%) excluding divestitures and FX effects |
1.7 |
% |
|
11.4 |
% |
Financial Outlook:
Based on current market conditions and assuming that the impacts of global inflationary pressures, interest rate hikes and supply chain costs do not impede economic activity further, the Company is providing the following outlook for 2023:
-
Full year revenue of
to$620 million .$670 million - Sequential quarterly revenue growth, notably higher in the second half
-
Based on current logistics and materials costs, full year gross margins of
48.0% to49.0% , with improved year-over-year growth in the second half of 2023. -
Full year-operating expenses of
to$290 million .$300 million -
Full year non-GAAP operating margins of
2.5% to3.5% with improving profitable contribution through the year. -
GAAP net loss of
to$78 million , or ($57 million ) to ($1.12 ) per diluted share.$0.83 -
Non-GAAP net income of
to$9 million , or$17 million to$0.12 per diluted share.$0.24 -
Adjusted EBITDA of
to$35 million .$50 million -
Capital expenditures of
to$20 million .$25 million
Non-GAAP earnings guidance excludes
Appropriate reconciliations between GAAP and non-GAAP financial measures are provided in a table at the end of our press release and slide presentation, with itemized detail concerning the non-GAAP financial measures.
The Company plans to webcast its conference call to discuss its fourth quarter 2022 financial results on
The investor conference call will be available via live webcast on the Stratasys Web site at investors.stratasys.com, or directly at the following web address:
https://event.choruscall.com/mediaframe/webcast.html?webcastid=K6UFH5he
To participate by telephone, the
To learn more about
Cautionary Statement Regarding Forward-Looking Statements
The statements in this press release regarding
Use of Non-GAAP Financial Measures
The non-GAAP data included herein, which excludes certain items as described below, are non-GAAP financial measures. Our management believes that these non-GAAP financial measures are useful information for investors and shareholders of our company in gauging our results of operations (i) on an ongoing basis after excluding mergers, acquisitions and divestments related expense or gains and reorganization-related charges or gains, and legal provisions and (ii) excluding non-cash items such as stock-based compensation expenses, acquired intangible assets amortization, including intangible assets amortization related to equity method investments, impairment of long-lived assets and goodwill, revaluation of our investments and the corresponding tax effect of those items. These non-GAAP adjustments either do not reflect actual cash outlays that impact our liquidity and our financial condition or have a non-recurring impact on the statement of operations, as assessed by management. These non-GAAP financial measures are presented to permit investors to more fully understand how management assesses our performance for internal planning and forecasting purposes. The limitations of using these non-GAAP financial measures as performance measures are that they provide a view of our results of operations without including all items indicated above during a period, which may not provide a comparable view of our performance to other companies in our industry. Investors and other readers should consider non-GAAP measures only as supplements to, not as substitutes for or as superior measures to, the measures of financial performance prepared in accordance with GAAP. Reconciliation between results on a GAAP and non-GAAP basis is provided in a table below.
Consolidated Balance Sheets | ||||||||
(in thousands, except share data) | ||||||||
|
|
|||||||
2022 |
2021 |
|||||||
ASSETS | ||||||||
Current assets | ||||||||
Cash and cash equivalents | $ |
150,470 |
|
$ |
243,179 |
|
||
Short-term deposits |
|
177,367 |
|
|
259,000 |
|
||
Accounts receivable, net of allowance for credit losses of |
|
144,739 |
|
|
129,382 |
|
||
Inventories |
|
194,054 |
|
|
129,147 |
|
||
Prepaid expenses |
|
5,767 |
|
|
6,871 |
|
||
Other current assets |
|
27,823 |
|
|
33,123 |
|
||
Total current assets |
|
700,220 |
|
|
800,702 |
|
||
Non-current assets | ||||||||
Property, plant and equipment, net |
|
195,063 |
|
|
203,295 |
|
||
|
64,953 |
|
|
65,144 |
|
|||
Other intangible assets, net |
|
121,402 |
|
|
152,244 |
|
||
Operating lease right-of-use assets |
|
18,122 |
|
|
14,651 |
|
||
Long-term investments |
|
141,610 |
|
|
28,667 |
|
||
Other non-current assets |
|
18,420 |
|
|
12,519 |
|
||
Total non-current assets |
|
559,570 |
|
|
476,520 |
|
||
Total assets | $ |
1,259,790 |
|
$ |
1,277,222 |
|
||
LIABILITIES AND EQUITY | ||||||||
Current liabilities | ||||||||
Accounts payable | $ |
72,921 |
|
$ |
51,976 |
|
||
Accrued expenses and other current liabilities |
|
45,912 |
|
|
55,358 |
|
||
Accrued compensation and related benefits |
|
34,432 |
|
|
44,684 |
|
||
Deferred revenues - short term |
|
50,220 |
|
|
51,174 |
|
||
Operating lease liabilities - short term |
|
7,169 |
|
|
7,276 |
|
||
Total current liabilities |
|
210,654 |
|
|
210,468 |
|
||
Non-current liabilities | ||||||||
Deferred revenues - long term |
|
25,214 |
|
|
21,133 |
|
||
Deferred income taxes - long term |
|
5,638 |
|
|
7,341 |
|
||
Operating lease liabilities - long term |
|
10,670 |
|
|
7,693 |
|
||
Contingent consideration - long term |
|
23,707 |
|
|
53,478 |
|
||
Other non-current liabilities |
|
24,475 |
|
|
21,095 |
|
||
Total non-current liabilities |
|
89,704 |
|
|
110,740 |
|
||
Total liabilities |
|
300,358 |
|
|
321,208 |
|
||
Equity | ||||||||
Ordinary shares, |
||||||||
shares; 67,086 thousands shares and 65,677 thousands shares issued |
|
187 |
|
|
182 |
|
||
and outstanding at |
|
3,048,915 |
|
|
3,012,481 |
|
||
Additional paid-in capital | ||||||||
Accumulated other comprehensive loss |
|
(12,818 |
) |
|
(8,771 |
) |
||
Accumulated deficit |
|
(2,076,852 |
) |
|
(2,047,878 |
) |
||
Total equity |
|
959,432 |
|
|
956,014 |
|
||
Total liabilities and equity | $ |
1,259,790 |
|
$ |
1,277,222 |
|
Consolidated Statements of Operations | ||||||||||||||||
(in thousands, except per share data) | ||||||||||||||||
Three Months Ended |
Twelve Ended |
|||||||||||||||
2022 |
2021 |
2022 |
2021 |
|||||||||||||
(unaudited) |
(unaudited) |
|||||||||||||||
Net sales | ||||||||||||||||
Products | $ |
111,197 |
|
$ |
118,040 |
|
$ |
452,124 |
|
$ |
417,557 |
|
||||
Services |
|
48,062 |
|
|
48,976 |
|
|
199,359 |
|
|
189,662 |
|
||||
|
159,259 |
|
|
167,016 |
|
|
651,483 |
|
|
607,219 |
|
|||||
Cost of sales | ||||||||||||||||
Products |
|
58,180 |
|
|
59,470 |
|
|
234,601 |
|
|
210,941 |
|
||||
Services |
|
32,431 |
|
|
34,503 |
|
|
140,415 |
|
|
136,200 |
|
||||
|
90,611 |
|
|
93,973 |
|
|
375,016 |
|
|
347,141 |
|
|||||
Gross profit |
|
68,648 |
|
|
73,043 |
|
|
276,467 |
|
|
260,078 |
|
||||
Operating expenses | ||||||||||||||||
Research and development, net |
|
21,387 |
|
|
22,620 |
|
|
92,876 |
|
|
88,303 |
|
||||
Selling, general and administrative |
|
45,665 |
|
|
66,584 |
|
|
240,750 |
|
|
250,937 |
|
||||
|
67,052 |
|
|
89,204 |
|
|
333,626 |
|
|
339,240 |
|
|||||
Operating loss |
|
1,596 |
|
|
(16,161 |
) |
|
(57,159 |
) |
|
(79,162 |
) |
||||
Gain from deconsolidation of subsidiary |
|
- |
|
|
- |
|
|
39,136 |
|
|
- |
|
||||
Gain from step acquisition |
|
- |
|
|
14,400 |
|
|
- |
|
|
14,400 |
|
||||
Financial income (expense), net |
|
2,309 |
|
|
(692 |
) |
|
229 |
|
|
(2,075 |
) |
||||
Income (loss) before income taxes |
|
3,905 |
|
|
(2,453 |
) |
|
(17,794 |
) |
|
(66,837 |
) |
||||
Income tax benefit (expense) |
|
(2,658 |
) |
|
(2,103 |
) |
|
(5,454 |
) |
|
3,906 |
|
||||
Share in profit (losses) of associated companies |
|
(3,637 |
) |
|
(280 |
) |
|
(5,726 |
) |
|
949 |
|
||||
Net income (loss) | $ |
(2,390 |
) |
$ |
(4,836 |
) |
$ |
(28,974 |
) |
$ |
(61,982 |
) |
||||
Net income (loss) per share | ||||||||||||||||
Basic | $ |
(0.04 |
) |
$ |
(0.07 |
) |
$ |
(0.44 |
) |
$ |
(0.98 |
) |
||||
Diluted | $ |
(0.04 |
) |
$ |
(0.07 |
) |
$ |
(0.44 |
) |
$ |
(0.98 |
) |
||||
Weighted average ordinary shares outstanding | ||||||||||||||||
Basic |
|
66,908 |
|
|
65,196 |
|
|
66,491 |
|
|
63,471 |
|
||||
Diluted |
|
66,908 |
|
|
65,196 |
|
|
66,491 |
|
|
63,471 |
|
Three Months Ended |
|||||||||||||||||||||||
|
2022 |
Non-GAAP |
2022 |
2021 |
Non-GAAP |
2021 |
|||||||||||||||||
|
GAAP |
Adjustments |
Non-GAAP |
GAAP |
Adjustments |
Non-GAAP |
|||||||||||||||||
|
|
||||||||||||||||||||||
|
Gross profit (1) | $ |
68,648 |
|
$ |
8,423 |
|
$ |
77,071 |
$ |
73,043 |
|
$ |
8,255 |
|
$ |
81,298 |
||||||
|
Operating income (loss) (1,2) |
|
1,596 |
|
|
3,456 |
|
|
5,052 |
|
(16,161 |
) |
|
17,822 |
|
|
1,661 |
||||||
|
Net income (loss) (1,2,3) |
|
(2,390 |
) |
|
6,940 |
|
|
4,550 |
|
(4,836 |
) |
|
5,355 |
|
|
519 |
||||||
|
Net income (loss) per diluted share (4) | $ |
(0.04 |
) |
$ |
0.11 |
|
$ |
0.07 |
$ |
0.07 |
|
$ |
0.08 |
|
$ |
0.01 |
||||||
|
|||||||||||||||||||||||
|
|||||||||||||||||||||||
|
|||||||||||||||||||||||
(1) |
Acquired intangible assets amortization expense |
|
7,297 |
|
|
6,024 |
|
||||||||||||||||
|
Non-cash stock-based compensation expense |
|
1,041 |
|
|
866 |
|
||||||||||||||||
|
Restructuring and other related costs |
|
85 |
|
|
1,185 |
|
||||||||||||||||
|
Impairment charges |
|
- |
|
|
180 |
|
||||||||||||||||
|
|
8,423 |
|
|
8,255 |
|
|||||||||||||||||
|
|||||||||||||||||||||||
(2) |
Acquired intangible assets amortization expense |
|
2,370 |
|
|
2,280 |
|
||||||||||||||||
|
Non-cash stock-based compensation expense |
|
7,664 |
|
|
6,971 |
|
||||||||||||||||
|
Restructuring and other related costs |
|
874 |
|
|
373 |
|
||||||||||||||||
|
Revaluation of investments |
|
560 |
|
|
(1,861 |
) |
||||||||||||||||
|
Contingent consideration |
|
(19,490 |
) |
|
(20 |
) |
||||||||||||||||
|
Other expenses |
|
3,056 |
|
|
1,824 |
|
||||||||||||||||
|
|
(4,967 |
) |
|
9,568 |
|
|||||||||||||||||
|
|
3,456 |
|
|
17,822 |
|
|||||||||||||||||
|
|||||||||||||||||||||||
(3) |
Corresponding tax effect |
|
1,770 |
|
|
1,906 |
|
||||||||||||||||
|
Equity method related amortization, divestments and impairments |
|
1,714 |
|
|
27 |
|
||||||||||||||||
|
Gain from obtaining control |
|
- |
|
|
(14,400 |
) |
||||||||||||||||
|
$ |
6,940 |
|
$ |
5,355 |
|
|||||||||||||||||
|
|||||||||||||||||||||||
(4) |
Weighted average number of ordinary shares outstanding - Diluted |
|
66,908 |
|
|
67,231 |
|
65,196 |
|
|
66,820 |
|
Twelve Months Ended |
|||||||||||||||||||||||
|
2022 |
Non-GAAP |
2022 |
2021 |
Non-GAAP |
2021 |
||||||||||||||||||
|
GAAP |
Adjustments |
Non-GAAP |
GAAP |
Adjustments |
Non-GAAP |
||||||||||||||||||
|
|
|||||||||||||||||||||||
|
Gross profit (1) | $ |
276,467 |
|
$ |
36,016 |
|
$ |
312,483 |
$ |
260,078 |
|
$ |
30,447 |
|
$ |
290,525 |
|
||||||
|
Operating income (loss) (1,2) |
|
(57,159 |
) |
|
70,691 |
|
|
13,532 |
|
(79,162 |
) |
|
77,479 |
|
|
(1,683 |
) |
||||||
|
Net income (loss) (1,2,3) |
|
(28,974 |
) |
|
39,235 |
|
|
10,261 |
|
(61,982 |
) |
|
57,639 |
|
|
(4,343 |
) |
||||||
|
Net income (loss) per diluted share (4) | $ |
(0.44 |
) |
$ |
0.59 |
|
$ |
0.15 |
$ |
(0.98 |
) |
$ |
0.91 |
|
$ |
(0.07 |
) |
||||||
|
||||||||||||||||||||||||
|
||||||||||||||||||||||||
|
||||||||||||||||||||||||
(1) |
Acquired intangible assets amortization expense |
|
28,158 |
|
|
22,392 |
|
|||||||||||||||||
|
Non-cash stock-based compensation expense |
|
4,082 |
|
|
3,093 |
|
|||||||||||||||||
|
Restructuring and other related costs |
|
(174 |
) |
|
1,642 |
|
|||||||||||||||||
|
Impairment charges |
|
3,949 |
|
|
3,320 |
|
|||||||||||||||||
|
|
36,016 |
|
|
30,447 |
|
||||||||||||||||||
|
||||||||||||||||||||||||
(2) |
Acquired intangible assets amortization expense |
|
8,950 |
|
|
8,878 |
|
|||||||||||||||||
|
Non-cash stock-based compensation expense |
|
29,378 |
|
|
27,885 |
|
|||||||||||||||||
|
Impairment of long-lived assets |
|
- |
|
|
1,447 |
|
|||||||||||||||||
|
Restructuring and other related costs |
|
2,737 |
|
|
2,743 |
|
|||||||||||||||||
|
Revaluation of investments |
|
3,777 |
|
|
(1,303 |
) |
|||||||||||||||||
|
Contingent consideration |
|
(18,293 |
) |
|
570 |
|
|||||||||||||||||
|
Other expenses |
|
8,126 |
|
|
6,812 |
|
|||||||||||||||||
|
|
34,676 |
|
|
47,032 |
|
||||||||||||||||||
|
|
70,691 |
|
|
77,479 |
|
||||||||||||||||||
|
||||||||||||||||||||||||
(3) |
Corresponding tax effect |
|
4,988 |
|
|
(864 |
) |
|||||||||||||||||
|
Equity method related amortization, divestments and impairments |
|
2,285 |
|
|
(4,576 |
) |
|||||||||||||||||
|
Finance expenses |
|
406 |
|
|
- |
|
|||||||||||||||||
|
Gain from deconsolidation of subsidiary |
|
(39,136 |
) |
||||||||||||||||||||
|
Gain from obtaining control |
|
(14,400 |
) |
||||||||||||||||||||
|
||||||||||||||||||||||||
|
$ |
39,235 |
|
$ |
57,639 |
|
||||||||||||||||||
|
||||||||||||||||||||||||
(4) |
Weighted average number of ordinary shares outstanding - Diluted |
|
66,491 |
|
|
67,068 |
|
63,471 |
|
|
63,471 |
|
Reconciliation of GAAP to Non-GAAP Forward Looking Guidance | ||||
Fiscal Year 2023 | ||||
(in millions, except per share data) | ||||
GAAP net loss | ( |
|||
Adjustments | ||||
Stock-based compensation expense | ||||
Intangible assets amortization expense | ||||
Reorganization and other | ||||
Tax expense (benefit) related to Non-GAAP adjustments | ||||
Non-GAAP net income | ||||
GAAP loss per share | ( |
|||
Non-GAAP diluted earnings per share |
View source version on businesswire.com: https://www.businesswire.com/news/home/20230302005293/en/
CCO, VP Investor Relations
Yonah.Lloyd@stratasys.com
Source:
FAQ
What were Stratasys' fourth quarter 2022 earnings results?
How did Stratasys perform in the full year 2022?
What is Stratasys' outlook for 2023?